Ireland· IE-PA-EU/1/13/842/010-018
Incresync 12.5 mg/45 mg film-coated tablets
A combinations of oral blood glucose lowering drugs product containing alogliptin (as benzoate) + pioglitazone (as hydrochloride), registered in Ireland by Takeda Pharma A/S.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Alogliptin (as benzoate) + Pioglitazone (as hydrochloride)
- Manufacturer
- Takeda Pharma A/S
- Country
- Ireland (IE)
- ATC code
- A10BD
- ATC class
- Combinations of oral blood glucose lowering drugs
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/13/842/010-018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alogliptin (as benzoate) + pioglitazone (as hydrochloride) in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d645f82-e724-4bf3-92a4-2ff128f7f327 GET /v1/drugs/8d645f82-e724-4bf3-92a4-2ff128f7f327?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A10BD"
],
"strength": null,
"pa_number": "EU/1/13/842/010-018",
"substances": [
"Alogliptin (as benzoate)",
"Pioglitazone (as hydrochloride)"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about alogliptin (as benzoate) + pioglitazone (as hydrochloride).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.